Clinical trials: Allografted With Myeloablative Conditioning

Allografted With Myeloablative Conditioning

Complement and Graft-versus-host Disease

• Completed
• Age: 18 to 65 years

Allogeneic haematopoietic stem cell transplantation (HSCT) often remains the only curative treatment for haematological malignancies.

Trial name

NCT01520623

Testing

Serum concentration /Serum inflammatory

Where

3 sites in France

Volunteers

70 people

Sponsor

Assistance Publique - Hôpitaux de Paris